Disease Burden
RELAPSES GREATLY
INCREASE BURDEN ON
NMOSD PATIENTS
*Based on a review of 19 studies reporting crude and adjusted prevalence estimates for NMOSD overall, as well as by region and ancestry.2
This is a hypothetical patient.
Know more about NMOSD Disease Burden
Almost half of patients (48%) with nmosd can experience one or more relapses, resulting in hospital/inpatient admissions and ambulatory/outpatient treatment within 2 years.2†
Quality Of Life Is Reduced In Patients With NMOSD3
Percentage Of Patients With NMOSD Reporting Moderate Or Severe Symptoms (N=552)3**
Meet Shamma, a patient with AQP4-IgG+ NMOSD
ATTACKS CAN BE RECURRENT AND MAY PREDICT FUTURE DISABILITY6,7
NMOSD Neuromyelitis optica spectrum disorder
*Assessment of physical, emotional, and socioeconomic burden of NMOSD on QoL among 193 patients.
† A retrospective, observational cohort study from a US claims database including 1363 adult patients with NMOSD; the mean age was 44.9 years, and 75.3% were female.
**Retrospective, observational study including 522 patients with NMOSD from PatientsLikeMe (PLM), an online patient community
References:
1) Beekman J, et al. Neuromyelitis optica spectrum disorder: Patient experience and quality of life. Neurol Neuroimmunol Neuroinflamm. 2019;6(4):e580.
2) Royston M, et al. Neuromyelitis Optica Spectrum Disorder: Clinical Burden and Cost of Relapses and Disease-Related Care in US
Clinical Practice. Neurol Ther. 2021;10(2):767–783.
3) Eaneff S, et al. Patient perspectives on neuromyelitis optica spectrum disorders: Data from the PatientsLikeMe online community.
Mult Scler Relat Disord. 2017;17:116–122.